Výsledky vyhledávání
- 1.ŠŤASTNÁ MARKOVÁ, M.; HAMŠÍKOVÁ, E.; HAINZ, P.; HUBÁČEK, P.; KROUTILOVÁ, M.; KRYŠTOFOVÁ, J.; LUDVÍKOVÁ, V.; MUSIL, J.; PECHERKOVÁ, P.; SALÁKOVÁ, M.; ŠROLLER, V.; VYDRA, J.; NĚMEČKOVÁ, Š.G Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of BK virus-associated haemorrhagic cystitis after allogeneic HSCT. Vaccines. 2021, vol. 9, no. 11, art. no. 1226. ISSN 2076-393X.
- 2.KAŠTÁNKOVÁ, I.; ŠTACH, M.; ŽIŽKOVÁ, H.; PTÁČKOVÁ, P.; ŠMILAUEROVÁ, K.; MUCHA, M.; ŠROLLER, V.; OTÁHAL, P.G Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells. Molecular therapy-methods & clinical development. 2021, vol. 23, no. [December], s. 119-127. ISSN 2329-0501.
- 3.SALÁKOVÁ, M.G; KOŠLABOVÁ, E.; VOJTĚCHOVÁ, Z.; TACHEZY, R.; ŠROLLER, V. The detection of human polyomaviruses MCPyV, HPyV6, and HPyV7 in malignant and non-malignant tonsillar tissues. Journal of medical virology. 2016, vol. 88, no. 4, s. 695-702. ISSN 0146-6615.
- 4.ŠROLLER, V.G; HAMŠÍKOVÁ, E.; LUDVÍKOVÁ, V.; MUSIL, J.; NĚMEČKOVÁ, Š.; SALÁKOVÁ, M. Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors. Journal of medical virology. 2016, vol. 88, no. 7, s. 1254-1261. ISSN 0146-6615.
- 5.NEMECKOVA, S.G; SROLLER, V.; STASTNA MARKOVA, M. Evolution of human cytomegalovirus-seronegative donor/-seropositive recipient high-risk combination frequency in allogeneic hematopoietic stem cell transplantations at Institute of Hematology and Blood Transfusion during 1995-2014. Transplant infectious disease. 2016, vol. 18, no. 2, s. 297-301. ISSN 1398-2273.
- 6.NEMECKOVA, S.G; KRYSTOFOVA, J.; BABIAROVA, K.; HAINZ, P.; MUSIL, J.; SROLLER, V.; MALY, M.; STASTNA MARKOVA, M. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs. Transplant infectious disease. 2016, vol. 18, no. 3, s. 381-389. ISSN 1398-2273.
- 7.MACKOVA, J.; ZURKOVA, K.; SROLLER, V.; MUSIL, J.; BABIAROVA, K.; NEMECKOVA, S. In vitro generation of HCMV specific T-lymphocytes. Journal of clinical virology. 2015, vol. 70, no. S1, s. S116. ISSN 1386-6532.
- 8.ŠROLLER, V. Epidemiologie polyomavirových infekcí. [Předneseno: Odborná konference: Konzultační den, NRL pro papillomaviry. Praha, 9.6.2015.].
- 9.BABIAROVA, K.; KRYSTOFOVA, J.; HAINZ, P.; STASTNA, M.; MACKOVA, J.; MUSIL, J.; SROLLER, V.; NEMECKOVA, S. Detection of anti-HCMV T cell response of potential recipients and donors in cellular immunotherapy of leukemic patients after transplantation of hematopoietic stem cells. [Prezentováno: 17th Annual Meeting of the European Society for Clinical Virology. Praha, 28.9.-1.10.2014.].
- 10.SALÁKOVÁ, M.; ŠROLLER, V.; KOŠLABOVÁ, E.; SOCHOROVÁ, Z.; TACHEZY, R. The detection of MCPyV, HPyV6, and HPyV7 in tumor and non-tumor tonsillar tissues. [Předneseno: Emerging Oncogenic Viruses. San Pietro in Bevagna, Italy, 4.-8.6.2014.].